<DOC>
	<DOCNO>NCT00840216</DOCNO>
	<brief_summary>The objective study compare relative bioequivalence test clarithromycin extend release formulation equivalent oral dose commercially available extended release clarithromycin test population 22 adult subject feed condition .</brief_summary>
	<brief_title>Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions .</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Inclusion Criteria Sex : Males female surgically sterile postmenopausal least 6 month ; similar proportion prefer . Age : At least 18 year . Qualifying subject must good health physical condition determine medical history , complete physical examination , laboratory test , obtain within four ( 4 ) week prior study start . The subject may history significant past illness expect affect investigation . The normal status subject confirm follow procedure : 1 . Laboratory Tests : Hemoglobin , hematocrit , RBC , WBC , differential count , serum electrolyte ( Nz , K , Cl ) , fast blood glucose , BUN , bilirubin , creatinine , AST , ALT , LD , alkaline phosphatase urinalysis . HIV , Hepatitis B , Hepatitis C , drug abuse test do screening purpose . Urine drug abuse test repeat checkin . Female subject serum pregnancy test do screen urine pregnancy test prior study period checkin . Postmenopausal females FSH ( Follicle Stimulating Hormone ) level perform confirm postmenopausal status . Laboratory value great Â±20 % normal range qualify unless specifically accept ( comment ) Principal Investigator . Results HIV , Hepatitis B , Hepatitis C , drug abuse must negative nonreactive subject qualify study . 2 . Electrocardiogram A 12lead electrocardiogram ( ECG ) obtain subject . The original tracing , plus interpretation , include case report form packet . Subjects must read sign Consent Form . Exclusion Criteria Subjects comply inclusion criterion must exclude study . In addition , one condition list exclude subject study : 1 . History treatment alcoholism , substance abuse , drug abuse within past 24 month . 2 . History malignancy , stroke , diabetes , cardiac , renal liver disease , serious illness . 3 . History treatment gastrointestinal disorder within past 5 year . 4 . History treatment asthma within past five ( 5 ) year . 5 . History diarrhea within 24 hour prior dose . 6 . Females pregnant lactating . 7 . History hypersensitivity clarithromycin macrolide antibiotic . Conditions upon screen might contraindicate require caution use administration dexmethylphenidate hydrochloride , include : 1 . Sitting systolic blood pressure 90 mm Hg , diastolic pressure 50 mm Hg . 2 . Heart rate le 50 beat per minute 5minute rest seat position . Inability read and/or sign consent form . Treatment investigational drug four ( 4 ) week prior initial dose study . Subjects donate blood within four ( 4 ) week prior initial dose study . Subjects smoke use tobacco product currently use nicotine product ( patch , gum , etc. ) . Three ( 3 ) consecutive month abstinence require .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>